DNA sequencing stands out as the dominant application, with nanopore-based platforms delivering real-time, long-read sequencing capabilities that are fundamentally reshaping pathogen detection, oncology diagnostics, and the pursuit of personalised medicine. The Asia-Pacific region is emerging as a high-growth market.